Overview of Dr. Andrews
Dr. Jinsy Andrews is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, James J. Peters Veterans Affairs Medical Center, and NYU Langone Hospitals. She received her medical degree from Albany Medical College and has been in practice 16 years. She is one of 485 doctors at New York-Presbyterian Hospital and one of 19 doctors at James J. Peters Veterans Affairs Medical Center who specialize in Neurology. She has more than 50 publications and over 500 citings.
Office
710 W 168th St
# NI-3
New York, NY 10032Fax+1 212-305-1304
Education & Training
Columbia University Mailman School of Public HealthMSc, Biostatistics, 2007 - 2009
New York Presbyterian Hospital (Cornell Campus)Fellowship, Clinical Neurophysiology, 2006 - 2007- New York Presbyterian Hospital (Columbia Campus)Fellowship, Neuromuscular Medicine (Neurology), 2005 - 2006
University of ConnecticutResidency, Neurology, 2002 - 2005- University of ConnecticutInternship, Internal Medicine, 2001 - 2002
Albany Medical CollegeClass of 2001
Certifications & Licensure
CA State Medical License 2016 - 2026
NY State Medical License 2005 - 2026
NJ State Medical License 2021 - 2025
CT State Medical License 2010 - 2017- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- Fellow of the American Academy of Neurology American Academy of Neurology (AAN), 2018
- Diamond Award for ALS Research Wings Over Wall Street/MDA, 2009
Clinical Trials
- Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2009 Jan 01
- Ciprofloxacin/Celecoxib Combination in Patients With ALS Start of enrollment: 2019 Dec 09
Publications & Presentations
PubMed
- 54 citationsAssociation Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Late...Jinsy A. Andrews, Lisa Meng, Sarah Kulke, Stacy A. Rudnicki, Andrew A. Wolff
JAMA Neurology. 2018-01-01 - 5 citationsCorrection to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study.Michael Benatar, Joanne Wuu, Peter M Andersen, Robert C Bucelli, Jinsy A Andrews
Neurotherapeutics. 2022-09-01 - 66 citationsReal-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis.Jinsy A. Andrews, Carlayne E. Jackson, Terry Heiman-Patterson, Paolo Bettica, Benjamin Rix Brooks
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2020-06-23
Press Mentions
ProJenX Announces Formation of Clinical Advisory BoardAugust 27th, 2024- New ALS Drug Relyvrio Approved by FDA: The Debate over Its EffectivenessSeptember 30th, 2022
- New Drugs for ALS and Alzheimer’s Show Great PromiseSeptember 30th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
- American Neurological Association - ANAMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
